AnalystsEric SchmidtEric Schmidt's Stock Forecasts
AnalystsEric Schmidt
Sectors:
Industries:
Analyst Ranking
Top 4%
#184 out of 5510 analysts
Average Return
+51.55%
Win Rate
37%17 out of 46
Risk vs Reward
Poor
Good
Eric Schmidt's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cidara Therapeutics IncCDTX | +1,121.74% | $18.12 | $221.38 | 2025-01-27 - 2026-01-06 | Strong Buy |
Cidara Therapeutics IncCDTX | +745.93% | $26.17 | $221.38 | 2025-06-10 - 2026-01-06 | Strong Buy |
Alumis IncALMS | +601.96% | $3.57 | $25.06 | 2025-03-20 - 2026-03-20 | Strong Buy |
Tango Therapeutics IncTNGX | +177.52% | $3.47 | $9.63 | 2024-12-05 - 2025-12-05 | Strong Buy |
Immatics NvIMTX | +150.25% | $4.00 | $10.01 | 2025-04-01 - 2026-04-01 | Strong Buy |
Eric Schmidt Analyst Color
Get additional color on Eric Schmidt's coverage of popular stocks
Eric Schmidt's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Odyssey Therapeutics IncODTX | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 3 months ago |
Generate Biomedicines IncGENB | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | 6 months ago |
Legend Biotech CorpLEGN | 3 | Strong Buy | $74.00 | +299.35% | Maintains | 9 months ago |
Verastem IncVSTM | 1 | Strong Buy | N/A | N/A | Assumes | a year ago |
Arcellx IncACLX | 1 | Hold | $88.00 | -23.52% | Assumes | a year ago |
Summit Therapeutics IncSMMT | 3 | Strong Buy | N/A | N/A | Reiterates | a year ago |
Scholar Rock Holding CorpSRRK | 1 | Strong Buy | N/A | N/A | Initiates Coverage On | a year ago |
Avidity Biosciences IncRNAM | 5 | Strong Buy | $96.00 | N/A | Reiterates | a year ago |
Prothena Corp Public Ltd CoPRTA | 2 | Hold | N/A | N/A | Reiterates | a year ago |
Cidara Therapeutics IncCDTX | 2 | Strong Buy | N/A | N/A | Reiterates | a year ago |
Immatics NvIMTX | 4 | Strong Buy | N/A | N/A | Reiterates | a year ago |
Alumis IncALMS | 4 | Strong Buy | N/A | N/A | Reiterates | a year ago |
Bicara Therapeutics IncBCAX | 2 | Strong Buy | $13.01 | N/A | Reiterates | 2 years ago |
Adc Therapeutics SaADCT | 2 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Crispr Therapeutics AgCRSP | 4 | Hold | N/A | N/A | Reiterates | 2 years ago |
Incyte CorpINCY | 6 | Hold | N/A | N/A | Reiterates | 2 years ago |
Agios Pharmaceuticals IncAGIO | 4 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Tango Therapeutics IncTNGX | 3 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Bluebird Bio IncBLUE | 2 | Hold | N/A | N/A | Reiterates | 2 years ago |
Immunocore Holdings PLCIMCR | 2 | Strong Buy | N/A | N/A | Reiterates | 2 years ago |
Biogen IncBIIB | 3 | Strong Buy | $292.00 | N/A | Reiterates | 2 years ago |
Vertex Pharmaceuticals IncVRTX | 1 | Strong Buy | $370.00 | N/A | Reiterates | 3 years ago |
Editas Medicine IncEDIT | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Bioverativ IncBIVV | 1 | Buy | N/A | N/A | Upgrades | 9 years ago |
G1 Therapeutics IncGTHX | 1 | Buy | $31.00 | N/A | Initiates Coverage On | 9 years ago |
Ovid Therapeutics IncOVID | 1 | Buy | N/A | N/A | Initiates Coverage On | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.